| Korea Post Marketing Surveillance (PMS) Study of Talzenna® (NCT04982848) | Pfizer | 2027-06-01 |
| A Study to Learn More About Tukysa Once it is Out in the Korean Market (NCT06873191) | Pfizer | 2027-01-01 |
| Symbiotic-GYN-18: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Advanced or Recurrent MMR-proficient Endometrial Cancer (NCT07578649) | Pfizer | 2026-10-09 |
| A Study to Learn About the Study Medicine NURTEC® ODT 75 mg After it is Released Into the Markets in Korea (NCT07497854) | Pfizer | 2026-10-01 |
| A Study to Learn How Different Preparations of Osivelotor Taste and Enter the Blood With Food or Liquids or With an Antacid in Healthy Adults (NCT06507904) | Pfizer | 2026-09-15 |
| A Study to Learn About Revaccination With a Vaccine Called RSVpreF in Immunocompromised Adults (NCT07768345) | Pfizer | 2026-08-31 |
| Tucatinib Continuation Study (NCT07768358) | Pfizer | 2026-08-24 |
| A Study to Learn About the Study Medicine Called Tilrekimig in People With Moderate-to-Severe Eczema (NCT07765888) | Pfizer | 2026-08-14 |
| A Study in Young People and Adults to Learn About the Medicine Ritlecitinib for Treatment of Patchy Hair Loss, Known by the Medical Term as Moderate Alopecia Areata (NCT07733765) | Pfizer | 2026-07-31 |
| Evaluating the Benefits of RSV Maternal Vaccination Using a Scottish National Dataset (NCT07235397) | Pfizer | 2026-07-30 |
| A Study to Learn About the Study Medicine Called Rimegepant in Adults When Used for the Prevention of Chronic Migraine (NCT07729462) | Pfizer | 2026-07-29 |
| A Study to Learn How Different Amounts of the Study Medicine Called PF-08642534 Are Tolerated and Act in the Body of People Who Have Obesity (NCT07731139) | Pfizer | 2026-07-28 |
| A Study to Evaluate 20vPnC in Healthy Chinese Infants (NCT07754539) | Pfizer | 2026-07-25 |
| A Study to Learn About How Food Affects the Uptake of Study Medicine Prifetrastat Into the Blood in Healthy Adults (NCT07731100) | Pfizer | 2026-07-24 |
| A Study to Learn How the Study Medicine Called PF-08653945 is Taken up Into the Blood in Adults With Overweight or Obesity (NCT07725809) | Pfizer | 2026-07-23 |
| A Study to Learn About the Study Medicine Called Ponsegromab in Adults With Lung Cancer-Associated Significant Weight Loss (NCT07663630) | Pfizer | 2026-07-22 |
| A Study to Find Out if the Medicine Called Rimegepant is Safe for Adults in India (NCT07685769) | Pfizer | 2026-07-17 |
| A Study to Learn About How Different Forms of Study Medicine Prifetrastat Are Taken Up Into the Blood in Healthy Adults (NCT07721402) | Pfizer | 2026-07-14 |
| Symbiotic-Lung-14: A Study to Learn About the Study Medicine Called PF08634404 in Combination With Chemotherapy in Adult Participants With Transformed Small Cell Lung Cancer (NCT07476287) | Pfizer | 2026-07-02 |
| An Open-Label Study to Evaluate PF-07994525 in Participants With Advanced Cancers (NCT07426757) | Pfizer | 2026-07-01 |
| Symbiotic-Lung-10: A Study to Learn About PF-08634404 Alone or in Combination in Early-stage or Locally Advanced NSCLC (NCT07489066) | Pfizer | 2026-06-30 |
| A Phase 3 Study in India to Describe the Safety and Immunogenicity of RSVpreF (NCT07653100) | Pfizer | 2026-06-22 |
| Real-World Effectiveness of RSV Vaccines Among Adults Using Target Trial Emulation in Epic Cosmos (NCT07673081) | Pfizer | 2026-06-20 |
| A Study to Learn How Different Amounts of the Study Medicine Called PF-08103402 Are Tolerated and Act in the Body in Healthy Adults or Adults With Mild To-moderate Asthma (NCT07660731) | Pfizer | 2026-06-17 |
| Study to Learn About Safety, Tolerability, and Immune Response of a Catch-up Pneumococcal Vaccine in Children and Adolescents (NCT07660198) | Pfizer | 2026-06-15 |
| A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity (NCT07595549) | Pfizer | 2026-06-10 |
| A Study to Learn About How a New Pneumococcal Vaccine Works in Infants. (NCT07629440) | Pfizer | 2026-05-29 |
| A Study to Learn About the Safety of Taking an Additional Dose of the Medicine Rimegepant in Adults With Migraine (NCT07609914) | Pfizer | 2026-05-28 |
| A Study of How the Medicine Called "Etrasimod" Works in Children With the Gut Disease Called Ulcerative Colitis (NCT07470879) | Pfizer | 2026-05-28 |
| A Study to Understand What the Body Does to the Study Medicine Called PF-07799544 When Taken by Healthy Adults (NCT07578636) | Pfizer | 2026-05-18 |
| A Study to Learn About Study Medicine Lorlatinib, as a First-line Treatment in Chinese Adults With ALK-positive a/mNSCLC (NCT07556549) | Pfizer | 2026-05-18 |
| Symbiotic-GI-16: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Gastroesophageal Cancer (NCT07392892) | Pfizer | 2026-05-14 |
| A Study to Learn How Different Forms of the Study Medicine Called PF-08049820 Are Absorbed and Eliminated in Healthy Adults (NCT07597928) | Pfizer | 2026-05-13 |
| A Study to Learn Safety and Immune Response to Study Vaccine -RSVpreF in Adults at High Risk of Severe RSV Disease. (NCT07543380) | Pfizer | 2026-05-11 |
| A Study of PF-08653945 and PF-08653944 in Adults With Overweight or Obesity (SOLIS-1) (NCT07575932) | Pfizer | 2026-05-11 |
| A Study to Compare the Amount of Two Forms of Tafamidis in the Blood of Healthy Adults Under Fasting Conditions (NCT07587697) | Pfizer | 2026-05-11 |
| A Real World Study of Elranatamab in Patients With RR Multiple Myeloma in Taiwan (NCT07391761) | Pfizer | 2026-05-11 |
| A Study to Learn How a Single Dose of the Study Medicine Called PF-08057418 is Tolerated in the Body of Healthy Adults. (NCT07575906) | Pfizer | 2026-05-08 |
| A Study to Compare the Blood Levels of Two Dosage Formulations of the Study Medicine in Healthy Adults (NCT07594769) | Pfizer | 2026-05-08 |
| A Study to Learn About the Safety of an Expanded Pneumococcal Vaccine in Healthy Infants (NCT07573462) | Pfizer | 2026-05-04 |
| A Study to Learn About Patients With Non-Small Cell Lung Cancer (NSCLC) Who Took Lorlatinib as Their First Treatment (NCT07567352) | Pfizer | 2026-05-01 |
| An Observational Study to Learn About Velsipity After Long Term Use in Patients With Ulcerative Colitis (NCT07459686) | Pfizer | 2026-04-27 |
| Real World Efficiency of Abrocitinib Treatment at Patients With Moderate to Severe Atopic Dermatitis Who Had Inadequate Response to Previous Biologic Therapies. (NCT06899204) | Pfizer | 2026-04-24 |
| A Study to Learn How Different Injector Pens Affect the Study Medicine Called Genotropin (Somatropin) Delivery and Taken up Into the Blood in Healthy Adults (NCT07542886) | Pfizer | 2026-04-22 |
| An Observational Study to Learn About the Medicine - BEVACIZUMAB BS [Pfizer] in Colorectal Cancer Patients From Japan. (NCT07527832) | Pfizer | 2026-04-20 |
| A Study to Learn About the Study Medicine - Zavicefta in Patients With Sepsis or Loss of Kidney Function in Japan (NCT06864585) | Pfizer | 2026-04-20 |
| A Study to Learn About the Medicine Called PF-08653944 in People With and Without Reduced Liver Function (NCT07519135) | Pfizer | 2026-04-15 |
| A Study of How Ibuzatrelvir is Taken up Into the Blood of Healthy Adults After Taking Different Tablets of Ibuzatrelvir (NCT07552779) | Pfizer | 2026-04-13 |
| A Study to Learn How Different Amounts of the Study Medicine Called PF-08065010 Are Tolerated and Act in the Body of Healthy Adults (NCT07235163) | Pfizer | 2026-04-13 |
| Phase 1 Study of PF-08046033 in Advanced Solid Tumors (NCT07519655) | Pfizer | 2026-04-08 |
| A Study to Learn About the Safety, Tolerability, and Immunogenicity of a Fifth Dose of 6-Valent OspA-Based Lyme Disease Vaccine (NCT07500506) | Pfizer | 2026-04-08 |
| A Study to Understand How a Study Medicine Called PF-07328948 is Absorbed and Processed in the Body of Healthy Male Adults (NCT07508228) | Pfizer | 2026-04-03 |
| A Retrospective Observational Study of Epidemiology and Outcomes in Transthyretin Amyloid Cardiomyopathy in Germany (NCT07494656) | Pfizer | 2026-04-02 |
| Describing Treatment Patterns and Creating an Updated Treatment Flow in an Ulcerative Colitis Population (NCT07177209) | Pfizer | 2026-04-01 |
| A Study to Compare the Amount of Two Forms of Tafamidis in the Blood of Healthy Adults Under Fed Conditions (NCT07470866) | Pfizer | 2026-03-23 |
| Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer (NCT07421700) | Pfizer | 2026-03-11 |
| A Study to Learn About How the Body Processes the Study Medicine Called PF-07328948 in Healthy Chinese Adults (NCT07455240) | Pfizer | 2026-03-02 |
| A Study to Learn About the Study Medicine (PF-08653944) in People With Obesity or Overweight and Type 2 Diabetes (T2D) (NCT07400653) | Pfizer | 2026-02-24 |
| A Study to Learn About mRNA Vaccines Against Influenza in Adults (NCT07431853) | Pfizer | 2026-02-23 |
| A Real-world Study of the First Treatment and Outcomes of Patients With Advanced or Metastatic Bladder Cancer (NCT07386847) | Pfizer | 2026-02-12 |
| Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer (NCT07227415) | Pfizer | 2026-02-10 |
| A Study to Learn How the Study Medicine Called PF-08653944 is Taken up Into the Blood in Adults With Overweight or Obesity (NCT07400679) | Pfizer | 2026-02-04 |
| Symbiotic-Lung-20: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Different Anticancer Agents in Advanced Cancers (NCT07227298) | Pfizer | 2026-01-30 |
| A Study to Learn How the Body Processes the Study Medicine PF-07328948 in People With Reduced Kidney Function (NCT07315360) | Pfizer | 2026-01-28 |
| A Study to Learn How Effective is PCV20 to Help Stop Adults Who Have a Higher Chance of Getting Pneumonia (NCT07251465) | Pfizer | 2026-01-21 |
| Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NCT07222566) | Pfizer | 2026-01-06 |
| A Study to Learn if Itraconazole Changes How the Body Processes PF-07248144 (Study Medicine) (NCT07335419) | Pfizer | 2026-01-02 |
| A Study to Learn About the Study Medicine Called PF-08032562 in People With Advanced or Metastatic Solid Tumors (NCT07318805) | Pfizer | 2025-12-23 |
| Utilization and Effectiveness of Ritlecitinib in a Real-World Population With Severe AA in the US (NCT07226531) | Pfizer | 2025-12-22 |
| A Study to Learn How the Body Processes the Study Medicine PF-07328948 in People With and Without Reduced Liver Function (NCT07269301) | Pfizer | 2025-12-22 |
| Efficacy and Safety of MET097 Once-Weekly in People With Overweight or Obesity (NCT07311850) | Pfizer | 2025-12-19 |
| Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer (NCT07222800) | Pfizer | 2025-12-11 |
| A Study to Learn How Different Amounts of the Study Medicine Called PF-07985631 Are Tolerated and Act in the Body in Healthy Adults (NCT07235150) | Pfizer | 2025-12-11 |
| A Study to Learn About a Clostridioides Difficile Vaccine in People 65 Years of Age and Older (NCT07282665) | Pfizer | 2025-12-10 |
| A Long-term Study of the Medicine Called Abrocitinib in Children Aged 2 Years and Older With Moderate to Severe Eczema (NCT06807281) | Pfizer | 2025-12-02 |
| Evaluating ABRYSVO Maternal Vaccine Effectiveness Among Infants (NCT07249320) | Pfizer | 2025-12-01 |
| Symbiotic-GI-13: A Study to Learn About Study Medicine Called PF-08634404 as a Single Treatment and Combination Treatment in Adult Participants With a Liver Cancer Called Hepatocellular Carcinoma, That is Too Advanced to be Removed by Surgery and May Have Spread to Other Parts of the Body. (NCT07227012) | Pfizer | 2025-12-01 |
| A Study to Compare Blood Levels of Different Dosage Formulations of the Study Medicine That Is a CGRP Receptor Antagonist in Healthy Adults (NCT07261371) | Pfizer | 2025-11-24 |
| A Study to Learn About Study Medicine Called PF-08049820 in People With Eczema (NCT07216027) | Pfizer | 2025-11-20 |
| A Study to Learn About Different Dosing Schedules of a Lyme Disease Vaccine in Healthy Adults (NCT07226882) | Pfizer | 2025-11-19 |
| A Study to Learn How the Body Processes the Study Medicine Called Vepdegestrant in People With Loss of Liver Function (NCT07231991) | Pfizer | 2025-11-18 |
| Consistency of Response With Rimegepant in Acute Treatment of Migraine (NCT06898047) | Pfizer | 2025-11-15 |
| A Study to Learn How Different Forms of the Study Medicine Called Prazosin Are Taken up Into the Blood in Healthy Adults (NCT07231978) | Pfizer | 2025-11-14 |
| A 16-Week Study to Learn About the Study Medicine Called Ritlecitinib in Adults With Long Lasting Painful Red Skin Lumps, Known by the Medical Term, Hidradenitis Suppurativa, or HS. (NCT07228390) | Pfizer | 2025-11-13 |
| A Study to Learn More About Prevenar 20 Once it is Out in the Korean Market (NCT06760208) | Pfizer | 2025-11-13 |
| A Study to Learn About the Study Medicine (Called PF-07868489) in People With Pulmonary Arterial Hypertension Who Have Previously Participated in a Clinical Study With PF-07868489 (NCT07073820) | Pfizer | 2025-11-10 |
| A Study to Learn About the Study Medicine PF-08052667 in People With Bladder Cancer (NCT07206225) | Pfizer | 2025-11-06 |
| A Study to Learn if a Medicine That Reduces Stomach Acid Affects the Blood Level of Study Medicine PF-08049820 in Healthy Chinese Adults. (NCT07284173) | Pfizer | 2025-11-03 |
| A Study to Learn About Ritlecitinib for the Potential Treatment of Chronic Spontaneous Urticaria in Adults. (NCT07219615) | Pfizer | 2025-10-30 |
| A Study to Learn About the Study Medicine -Hympavzi in Congenital Hemophilia Patients Without Inhibitors in Japan. (NCT07161687) | Pfizer | 2025-10-30 |
| A Study to Learn How Paxlovid [Nirmatrelvir-ritonavir/PF-07321332] Works in COVID-19 Patients Who Are Elderly or Have Medical Conditions. (NCT07261085) | Pfizer | 2025-10-27 |
| A Study to Learn How the Study Medicine Called Ibuzatrelvir is Taken up Into the Blood in Healthy Chinese Adults (NCT07235137) | Pfizer | 2025-10-16 |
| A Study to Understand What the Body Does to the Study Medicine Called PF-07248144 When Taken by Healthy Adults (NCT07423286) | Pfizer | 2025-10-13 |
| Study About Whether Atirmociclib/PF-07220060 Proportionally Increases Exposure as Dose Increases in Healthy Participants (NCT07215078) | Pfizer | 2025-10-08 |
| A Study to Learn If the Study Medicine Called PF-08049820 Changes How the Body Processes the Other Study Medicines Called Oral Contraceptives, Midazolam, and Dabigatran in Healthy Adult Female Participants (NCT07190430) | Pfizer | 2025-10-03 |
| A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC) (NCT07144280) | Pfizer | 2025-09-29 |
| This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve. (NCT07028853) | Pfizer | 2025-09-28 |
| A Study to Learn About the Study Medicine Paxlovid (Nirmatrelvir + Ritonavir) in Adults Aged 60 and Older Living in Korean Long-term Care Hospitals Who Have COVID-19 (NCT07089680) | Pfizer | 2025-09-23 |
| A Study to Learn About How the Study Medicines Called Itraconazole and Probenecid Change How the Body Processes PF-07220060 (NCT07160738) | Pfizer | 2025-09-22 |
| A Study to Learn if Multiple Doses of the Study Medicine Called Carbamazepine Changes How the Body Processes the Other Study Medicine PF-07248144 (NCT07198035) | Pfizer | 2025-09-18 |